Management of retinal detachment with severe proliferative vitreoretinopathy in Terson syndrome — case report by Nowomiejska, Katarzyna et al.
113Copyright © 2017 Via Medica, ISSN 2450–7873
CASE REPORTS
DOI: 10.5603/OJ.2017.0024
Corresponding author: 
Katarzyna Nowomiejska, Department of General Ophthalmology, Medical University of Lublin, Poland
Chmielna St. 1, 20–079 Lublin, Poland, e-mail: katarzyna.nowomiejska@umlub.pl
Management of retinal detachment with 
severe proliferative vitreoretinopathy in Terson 
syndrome — case report
Katarzyna nowomiejska, edyta Koman, robert rejdak
Department of General Ophthalmology, Medical University of Lublin, Poland
aBstraCt
We present a case of aneurysmal subarachnoid hemorrhage accompanied by a dense vitreous hemorrhage and sub-
sequent retinal detachment with strong proliferative retinopathy (PVR) in a young woman. The surgical treatment 
included vitrectomy with PVR removal, ILM peeling and silicone oil as a tamponade. In our case, the treatment 
resulted in recovery of vision and improved activities of daily living, although unusually vitreous hemorrhage was 
complicated with retinal detachment and strong PVR.
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introduCtion
Terson syndrome is defined as association of 
vitreous, subhyaloid (preretinal) or retinal haemor-
rhage with aneurysmal subarachnoid haemorrhage 
(SAH) or head trauma [1] in patients without oth-
er ocular pathology. The pathogenesis of Terson 
syndrome remains unclear [2]. Patients with suba-
rachnoid hemorrhage or subdural hemorrhage often 
present cognitive impairment which hinders accu-
rate diagnosis. Blood may enter into the vitreous 
cavity around the retinal vessels near the optic disc, 
inside the eye. The blood may spread intraretinally, 
sub-ILM, or along the retinal vessels [3]. Terson 
syndrome is named by a French ophthalmologist 
Albert Terson who published an article in 1900 [4]. 
Intraocular haemorrhages of different types have 
been documented in 8–20% of individuals with 
SAH [5, 6]. Terson syndrome represents 5.5% of 
all non-diabetic and non-traumatic vitreous haem-
orrhages [7].
In cases of minor bleeding spontaneous resorp-
tion may occur and vision is restored. In long-stand-
ing vitreous hemorrhage complications such as 
epiretinal membrane [8] and retinal detachment 
may occur and can lead to loss of vision or serious 
visual impairment [9]. 
The surgical procedure of choice in Terson syn-
drome is 20 or 23 gauge pars plana vitrectomy 
(PPV) [1]. We describe a case of retinal detachment 
with severe proliferative vitreoretinopathy (PVR) 
trated with vitrectomy and internal limiting mem-
brane (ILM) peeling.
Case desCription
Thirty-nine year old female presented with the 
haemorrhage into the vitreous cavity of the right 
eye as a result of cerebral aneurysm rupture of the 
right pericallosall artery. She inderwent a cerebral 
aneurysm clipping, Visual acuity was light percep-
tion in her right eye and 1.0 in the left eye. Fundus 
examination and ultrasonogrphy revealed vitre-
ous hemorrhage in the right eye. One month later 
23 gauge vitrectomy was performed in the right eye 
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Figure 1. Dense vitreous hemorrhage at the beginning of the vitrectomy
Figure 2. Retina at the posterior pole schrinked with advanced proliferative vitreoretinoapthy
with lens sparing. After removing dense vitreous 
hemorrhage (Fig. 1) schrinkage in the posterior pole 
was observed (PVR D1) (Fig. 2). Epiretinal PVR 
was removed with Eckart forceps and the retina was 
flattened with perfluorodecalin (Fig. 3). Internal 
limiting membrane peeling under perfluorodeca-
in was done after staining with indocyanine green 
(Fig. 4). After fluid-air exchange and removing of 
perfluorodecalin, 5000 cSt silicone oil was given as 
a tamponade. The visual acuity was 0.1 with +3D 
lens. Recovery of vision improved activities of daily 
living of the patient. Six months later phacoemulsi-
fication with intraocular lens implantation (Fig. 5) 
and silicon oil removal (Fig. 6). The visual acuity is 
still 0.1, but without correction.
disCussion
In this paper we present a rare case of vitreous 
hemorrhage in Terson syndrome complicated by 
retinal detachment. 
In general, the results of surgical treatment of 
Terson syndrome with PPV are very good and this 
surgical procedure provides generally good visual 
recovery (more than 0.5) [10, 3, 5]. Some authors 
state that PPV leads to rapid recovery irrespectively 
of the timing of vitrectomy or of preoperative visual 
acuity (nararayan). There is a success rate of 90% in 
a single surgery (garweg). In our case two vitrecto-
mies were performed to achieve the final outcome.
The most common complication of the vitreous 
hemorrhage in Terson syndrome is formation of 
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Figure 3. Flattening of the retina with perfluorodecalin after removing epiretinal proliferative vitreoretinopathy
Figure 4. Internal limiting membranę peeling under perfluorodecalin after staining with indocyanine green
Figure 5. Lens removal during the second vitrectomy
epiretinal membranes, observed in approximately 
16–59% of cases [11]. Strong PVR as a compli-
cation is quite rare in Terson syndrome. In the 
study of Narayanan there were 3 retinal detach-
ments in a group of 28 eyes with Terson syndrome 
following brain injury [1]. Retinal detachment as 
a complication of Terson sydrome was described 
for the first time in 1994 by Velikay and co-au-
thors [12]. The authors report five eyes from four 
patients with Terson syndrome due to spontane-
ous aneurysm rupture, in whom retinal detachment 
with PVR developed. The retina in all eyes could 
be reattached.
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Other complications of a long-lasting vitreous 
hemorrhage include: decline of retinal pigment epi-
thelium, atrophy the optic nerve, macular hole, retinal 
folds, cysts of the retina, cataract [13]. The incidence 
of intraocular pathologies has been found to be signif-
icantly higher in patients who lost consciousness at the 
onset of SAH [14]. Another finding that can be seen 
intraoperatively is perimacular ring [11]. It is a conse-
quence of a preretinal or retrohyaloideal haemorrhage.
PVR is a cellular reaction representing a vit-
reo-retinal wound healing response characterized 
by formation of periretinal non-vascular fibrocel-
lular membranes [15]. PVR develops as a relatively 
rare complication in about 8–10% of patients with 
primary retinal detachment. Evolving of PVR in 
long-existing haemorrhage may be caused by toxic 
effects of iron from red blood cells [16]. Intraocu-
lar bleeding can lead to proliferation of fibroblasts 
or glial cells. Posttraumatic vitreous hemorrhage 
is also strongly linked to less favorable outcomes 
and PVR development [17]. Close follow-up with 
regular B-scan ultrasonography examinations is rec-
ommended to detect PVR early preoperatively [13].
The surgical management of strong PVR is the 
same as in long-lasting rhematogenous retinal de-
tachment. If needed retinotomy is performed but 
it was not necessary in our case. The Silicone Study 
concluded that C3F8 gas or silicone oil is more effec-
tive than SF6 gas in the treatment of PVR cases [18]. 
In summary, our study provides addition-
al knowledge to the clinical picture of the Terson 
syndrome. Retinal detachment with PVR can be 
observed in the course of Terson syndrome and it 
requires removal of fibrocellular membranes, ILM 
peeling and silicone oil as a tamponade. 
Figure 6. Silicone oil removal during the second vitrectomy
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